Sarah Gheuens - Chief Medical Officer at Agios Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
AGIO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Sarah Gheuens - trading volume in the past year for Agios Pharmaceuticals, Inc.

Holdings reported by Sarah Gheuens for Agios Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 61.7K $2.7M $43.78 Nov 11, 2025 Direct
Restricted stock units 8.38K $403K $35.54 Jul 1, 2025 Direct Common stock
Stock options (right to buy) 26.1K Nov 11, 2025 Direct Common stock
Performance share units 6K Jun 24, 2025 Direct Common stock

Transactions reported by Sarah Gheuens for Agios Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.